Executives with Abbott Nutrition and two other major US infant formula providers offered largely different views of the market and of Abbott Nutrition’s recall leading to a shortage during a House Energy and Commerce subcommittee hearing on 25 May.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?